Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th: ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 ...

List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days. Pharming Group N.V.

Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second ...

The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect ...

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...

A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...

KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first ...

A Cambridge teen has become the first person in Europe to receive a “life-changing” drug for a rare genetic condition which contributed to the early deaths of her mother, aunt, uncle and ...